HomeBUSINESS
BUSINESS

Sawai Shooting for 12.7% Annual Growth for Upsher-Smith: Exec
(Dec.27.2017)

Kenzo Sawai, Executive Managing Director, Sawai Pharmaceutical
Japanese generic major Sawai Pharmaceutical is aspiring to achieve an annual growth rate of 12.7% through 2021 for Upsher-Smith Laboratories, an US peer it acquired in June, as its home market loses steam amid increasing pricing pressure, a company executive told Jiho ...
(LOG IN FOR FULL STORY)